[DPHARMA] YoY TTM Result on 30-Sep-2011 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- -0.34%
YoY- 3.91%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 171,671 152,048 132,969 137,291 129,092 123,399 125,457 5.36%
PBT 41,729 40,017 34,133 35,500 35,413 33,217 43,112 -0.54%
Tax -7,856 -9,845 -7,787 -6,509 -7,514 -7,310 -10,218 -4.28%
NP 33,873 30,172 26,346 28,991 27,899 25,907 32,894 0.48%
-
NP to SH 33,873 30,172 26,346 28,991 27,899 25,907 32,894 0.48%
-
Tax Rate 18.83% 24.60% 22.81% 18.34% 21.22% 22.01% 23.70% -
Total Cost 137,798 121,876 106,623 108,300 101,193 97,492 92,563 6.85%
-
Net Worth 187,531 179,017 167,991 162,353 148,494 143,023 137,432 5.31%
Dividend
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Div 24,291 20,128 18,318 5,014 22,910 9,814 11,102 13.93%
Div Payout % 71.71% 66.71% 69.53% 17.30% 82.12% 37.88% 33.75% -
Equity
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Net Worth 187,531 179,017 167,991 162,353 148,494 143,023 137,432 5.31%
NOSH 138,912 138,773 138,836 138,763 138,779 138,857 138,820 0.01%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin 19.73% 19.84% 19.81% 21.12% 21.61% 20.99% 26.22% -
ROE 18.06% 16.85% 15.68% 17.86% 18.79% 18.11% 23.93% -
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 123.58 109.57 95.77 98.94 93.02 88.87 90.37 5.35%
EPS 24.38 21.74 18.98 20.89 20.10 18.66 23.70 0.47%
DPS 17.50 14.50 13.20 3.61 16.50 7.06 8.00 13.92%
NAPS 1.35 1.29 1.21 1.17 1.07 1.03 0.99 5.30%
Adjusted Per Share Value based on latest NOSH - 138,763
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 17.85 15.81 13.82 14.27 13.42 12.83 13.04 5.36%
EPS 3.52 3.14 2.74 3.01 2.90 2.69 3.42 0.48%
DPS 2.53 2.09 1.90 0.52 2.38 1.02 1.15 14.03%
NAPS 0.195 0.1861 0.1746 0.1688 0.1544 0.1487 0.1429 5.31%
Price Multiplier on Financial Quarter End Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 -
Price 3.17 2.55 2.36 2.10 2.44 2.58 2.22 -
P/RPS 2.57 2.33 2.46 2.12 2.62 2.90 2.46 0.73%
P/EPS 13.00 11.73 12.44 10.05 12.14 13.83 9.37 5.60%
EY 7.69 8.53 8.04 9.95 8.24 7.23 10.67 -5.30%
DY 5.52 5.69 5.59 1.72 6.76 2.74 3.60 7.38%
P/NAPS 2.35 1.98 1.95 1.79 2.28 2.50 2.24 0.80%
Price Multiplier on Announcement Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 21/11/14 19/11/13 23/11/12 21/11/11 26/11/10 20/11/09 19/11/08 -
Price 3.01 2.56 2.28 2.10 2.38 2.49 2.20 -
P/RPS 2.44 2.34 2.38 2.12 2.56 2.80 2.43 0.06%
P/EPS 12.34 11.77 12.01 10.05 11.84 13.35 9.28 4.86%
EY 8.10 8.49 8.32 9.95 8.45 7.49 10.77 -4.63%
DY 5.81 5.66 5.79 1.72 6.93 2.84 3.64 8.10%
P/NAPS 2.23 1.98 1.88 1.79 2.22 2.42 2.22 0.07%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment